Management of external cephalic version in France: A national practice survey.
Atosiban
Breech presentation
ECV attempt
External cephalic version
Salbutamol
Tocolysis
Journal
Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
29
07
2021
revised:
16
09
2021
accepted:
30
09
2021
pubmed:
9
10
2021
medline:
13
1
2022
entrez:
8
10
2021
Statut:
ppublish
Résumé
The breech presentation represents 4,7% of deliveries at term. There is a method of external cephalic version (ECV) performed from 36 weeks of gestation. French guidelines for the clinical practice of ECV were published in 2020. To evaluate the national practices of ECV in French maternity units, especially on the use of tocolysis, 1 year after publication of the French clinical recommendations guidelines by the French national college of obstetricians and gynecologists (CNGOF). Data self-reported for this national descriptive study were collected from March to May 2021 by an online questionnaire distributed to all French maternities. The 25 items of the questionnaire collected information of maternity units, the general practice of ECV, use or not of tocolysis for ECV attempt and the relevance of a prospective study. Of the 517 French maternity units, 150 (29%) responded to the online survey. 95,3% systematically performed ECV. A Kleihauer test was routinely performed in 71 units (49.7%). A tocolysis was associated with ECV attempt in 52.4% of cases. The drugs used were intravenous atosiban (30,7%), mainly in levels 2b and 3 maternity units, intravenous salbutamol (24%), other mode of administration of salbutamol (14,7%) and oral nifedipine (22,6%) mainly in levels 1 and 2a maternity units. Adverse effects were described in 20%, mainly with the use of salbutamol (73,3%). 52.4% of the French maternity units surveyed used tocolysis for the ECV attempt, although it is systematically recommended. The choice of tocolytic drug differed according to the maternity units.
Identifiants
pubmed: 34624512
pii: S2468-7847(21)00176-8
doi: 10.1016/j.jogoh.2021.102239
pii:
doi:
Substances chimiques
Tocolytic Agents
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
102239Informations de copyright
Copyright © 2021. Published by Elsevier Masson SAS.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Any authors have financial competing interests. Vincent Dochez is a regular reviewer of the editorial board. Norbert Winer and Thibault Thubert are associate editors of this journal. The other authors have no non-financial competing interests.